Drugs / 4Plants/Azythromycin
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04501965 Background | Jun → Aug 2020 | COVID-19 | Institute for Research and Development of Medicinal and Food Plants of Guinea | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 4Plants/Azythromycin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04501965 ↗ |
| Route | Oral | “Participants received 4Plants powder in a 3.5g tea bag orally three times daily for 10 days and Azythromycine 250 mg orally at the rate of 2 tablets the first day, then one...” NCT04501965 ↗ |